Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 27 03 2018
accepted: 26 09 2018
pubmed: 27 11 2018
medline: 9 4 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Carbapenem-resistant Enterobacteriaceae (CRE), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPsA) are a serious cause of healthcare-associated infections, although the evidence for their control remains uncertain. We conducted a systematic review and reanalysis to assess infection prevention and control (IPC) interventions on CRE-CRAB-CRPsA in inpatient healthcare facilities to inform World Health Organization guidelines. Six major databases and conference abstracts were searched. Before-and-after studies were reanalyzed as interrupted time series if possible. Effective practice and organization of care (EPOC) quality criteria were used. Seventy-six studies were identified, of which 17 (22%) were EPOC-compatible and interrupted time series analyses, assessing CRE (n = 11; 65%), CRAB (n = 5; 29%) and CRPsA (n = 3; 18%). IPC measures were often implemented using a multimodal approach (CRE: 10/11; CRAB: 4/5; CRPsA: 3/3). Among all CRE-CRAB-CRPsA EPOC studies, the most frequent intervention components included contact precautions (90%), active surveillance cultures (80%), monitoring, audit and feedback of measures (80%), patient isolation or cohorting (70%), hand hygiene (50%), and environmental cleaning (40%); nearly all studies with these interventions reported a significant reduction in slope and/or level. The quality of EPOC studies was very low to low.

Identifiants

pubmed: 30475989
pii: 5201688
doi: 10.1093/cid/ciy752
pmc: PMC6389314
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-884

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

J Clin Epidemiol. 2016 Feb;70:191-9
pubmed: 26388040
Clin Infect Dis. 2013 Nov;57(9):1246-52
pubmed: 23946222
Infect Control Hosp Epidemiol. 2017 May;38(5):580-594
pubmed: 28294079
Am J Infect Control. 2011 Oct;39(8):671-677
pubmed: 21864942
J Intern Med. 2015 May;277(5):501-12
pubmed: 25556628
Clin Microbiol Infect. 2015 Dec;21(12):1057-66
pubmed: 26435462
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1315-1322
pubmed: 27609341
Lancet Infect Dis. 2007 Apr;7(4):282-8
pubmed: 17376385
Infect Control Hosp Epidemiol. 2009 Jul;30(7):611-22
pubmed: 19508124
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038269
Epidemiol Infect. 2012 Dec;140(12):2131-41
pubmed: 22335933
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Clin Infect Dis. 2017 May 15;64(10):1435-1444
pubmed: 28200000
Clin Microbiol Infect. 2017 Mar;23(3):188-196
pubmed: 27746394
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Expert Rev Anti Infect Ther. 2016 Aug;14(8):705-17
pubmed: 27348447
Am J Infect Control. 2014 Dec;42(12):1270-3
pubmed: 25465255
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55
pubmed: 24329732
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Clin Microbiol Infect. 2014 May;20(5):416-23
pubmed: 24131374
Antimicrob Resist Infect Control. 2017 Nov 15;6:113
pubmed: 29163939
Clinics (Sao Paulo). 2013;68(8):1128-33
pubmed: 24037009
Clin Microbiol Infect. 2010 Feb;16(2):102-11
pubmed: 20085604
Am J Infect Control. 2015 Nov;43(11):1171-7
pubmed: 26297525
Euro Surveill. 2014 Oct 30;19(43):
pubmed: 25375901
Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7
pubmed: 24915208
J Hosp Infect. 2011 Sep;79(1):49-53
pubmed: 21722990
Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164
pubmed: 18068815
Am J Infect Control. 2014 May;42(5):466-71
pubmed: 24773784
Infect Control Hosp Epidemiol. 2010 Jun;31(6):620-6
pubmed: 20370465
Lancet. 2005 Oct 8;366(9493):1246-7
pubmed: 16214584
Am J Infect Control. 2014 Sep;42(9):976-9
pubmed: 25179329
BMC Infect Dis. 2011 Oct 13;11:272
pubmed: 21995287
Clin Microbiol Infect. 2014 Sep;20(9):854-61
pubmed: 24980472
Clin Infect Dis. 2011 Apr 1;52(7):848-55
pubmed: 21317398
Infect Control Hosp Epidemiol. 2011 Dec;32(12):1158-65
pubmed: 22080653
Clin Infect Dis. 2015 Apr 15;60(8):1153-61
pubmed: 25537877
Emerg Microbes Infect. 2016 Mar 23;5:e27
pubmed: 27004762
Clin Microbiol Infect. 2015 Mar;21(3):242-7
pubmed: 25658534
Emerg Infect Dis. 2014 Jul;20(7):1170-5
pubmed: 24959688
Am J Infect Control. 2016 Nov 1;44(11):1374-1380
pubmed: 27156198
Int J Surg. 2010;8(5):336-41
pubmed: 20171303

Auteurs

Sara Tomczyk (S)

Infection Prevention and Control Global Unit, Service Delivery and Safety Department, World Health Organization, Switzerland.
Institute of Global Health, University of Geneva, Switzerland.

Veronica Zanichelli (V)

Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.

M Lindsay Grayson (ML)

Infectious Diseases Department, Austin Health, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia.
Department of Medicine, University of Melbourne, Victoria, Australia.

Anthony Twyman (A)

Infection Prevention and Control Global Unit, Service Delivery and Safety Department, World Health Organization, Switzerland.

Mohamed Abbas (M)

Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.

Daniela Pires (D)

Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.
Department of Infectious Diseases, Centro Hospitalar Lisboa Norte and Faculdade de Medicina da Universidade de Lisboa, Portugal.

Benedetta Allegranzi (B)

Infection Prevention and Control Global Unit, Service Delivery and Safety Department, World Health Organization, Switzerland.

Stephan Harbarth (S)

Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH